Biocompatibility evaluation of polyamide hemofiltration

Area of Science:

• Nephrology and Renal Replacement Therapy
• Biomaterials and Medical Device Science
• Immunology and Inflammation

Background:

• Postdilution hemofiltration using polyamide membranes is a common renal replacement technique.
• Limited data exists on the biocompatibility of polyamide membranes in hemofiltration.
• This study investigates the acute biocompatibility of polyamide hemofiltration.

Purpose of the Study:

• To assess the biocompatibility of polyamide hemofiltration.
• To evaluate complement activation, granulocyte degranulation, and cytokine expression.
• To analyze protein deposition on the polyamide membrane post-treatment.

Main Methods:

• Measured complement activation (C3a, C5a Des Arg) and granulocyte degranulation (alpha 1 elastase).
• Assessed IL-2 receptor expression (anti-TAC) and Beta 2-microglobulin removal.
• Utilized immunohistochemistry to analyze membrane protein layers and ELISA for cell-associated cytokines.

Main Results:

• Low complement activation observed with polyamide membranes, adjusted for hemoconcentration and surface area.
• Significant convective removal of Beta 2-microglobulin and activated anaphylatoxins (C3a, C5a).
• Coagulation factors deposited on the membrane; no immunoglobulins or complement factors detected. No significant cytokine induction.

Conclusions:

• Polyamide hemofiltration exhibits high biocompatibility.
• The synthetic membrane, sterile reinfusion fluid, and convective removal contribute to its safety.
• Effective removal of Beta 2-microglobulin and anaphylatoxins supports its clinical utility.